Research And Development In Nanotechnology federal obligations in FY2024

Nanotechnology R&D overlapping FY2024 — NAICS 541713

This page is a join: Research And Development In Nanotechnology (NAICS 541713) and FY2024. $1,052,663,601.95 is the obligation sum on that pair. It is not the government-wide FY2024 total on FY2024 federal spending, not every industry’s book on All industries, and not cash already paid. FY2024 is a closed fiscal year in the yearlyTrend series used here; later ingests can still restate the cell. Correlation is not causation: a large FY2024 cell does not prove federal demand caused activity in nanotechnology r&d, or the reverse.

FY2024 yearlyTrend is that fiscal year’s obligation sum tagged to NAICS 541713. A different fiscal year for the same code is a separate overlay. Calendar-year industry statistics are not this time key. NAICS 541713 is the industry parent without a year filter. FY2024 federal spending is the fiscal-year parent without this NAICS filter. All spending ties lists other pairs. Campaign-finance tables are a different dataset; donations do not fund these USAspending obligations.

Research And Development In Nanotechnology as the industry side

NAICS 541713 is Research And Development In Nanotechnology. The code marks research and development in nanotechnology. This packet lists no award recipients and no contractor names. Confusing this join with NAICS 541714 biotechnology R&D or a patent-office dashboard would be a different table. Packet facts on the industry side are the name Research And Development In Nanotechnology, code 541713, all-year obligations $1,318,843,185.11, and 680 awards. Any other recipient, program mix, or vendor list would be invented.

Readers sometimes treat a NAICS-year total as a budget Congress passed for a named activity. $1,052,663,601.95 is not that. It is the USAspending obligation rollup tagged to Research And Development In Nanotechnology in FY2024. Sibling or neighboring codes such as NAICS 541714 research and development in biotechnology except nanobiotechnology sit outside this cell. Cite Research And Development In Nanotechnology and FY2024. Do not invent vendors or award recipients.

FY2024 on nanotechnology R&D rows

Fiscal year 2024 is the yearlyTrend year key. It is not a calendar year and not a count of establishments in nanotechnology r&d. Awards that carry a different year sit outside this cell even if the NAICS is still 541713. FY2024 obligations of $1,052,663,601.95 are about 79.8% of the industry’s $1,318,843,185.11 all-year obligation total in this extract. Do not treat the all-year $1,318,843,185.11 as if it were the FY2024 headline.

680 awards as an industry table, not a lab census

The extract lists 680 awards on the Research And Development In Nanotechnology table. That is an industry-level award-record count, not a FY2024-only census published on this packet. Dividing $1,052,663,601.95 by 680 would mix a year cell with an all-year row count, so this page does not treat that quotient as a typical FY2024 invoice. Unique vendors are unpublished. Modifications can add rows without naming a new company.

Patent rankings the join cannot support

An obligation is a legal commitment. An outlay is a payment. $1,052,663,601.95 is the former. Citing it as cash already cleared in FY2024 over-reads the field. The join cannot say that FY2024 specialized in nanotechnology r&d because of federal demand. Keep $1,052,663,601.95 labeled as Research And Development In Nanotechnology obligations in FY2024. It is not biotechnology R&D except nanobiotechnology, an NSF award list, or a patent-count ranking.

Budget justifications, trade-association yearbooks, and private market-share reports answer other questions. They are not the source of this cell. If a chart mixes NAICS 541714 research and development in biotechnology except nanobiotechnology with NAICS 541713 in FY2024, the chart has left this join. Research topics, performers, and publications are unpublished on this packet.

Hubs for NAICS 541713 × FY2024

Open NAICS 541713 for the industry rollup, FY2024 federal spending for the fiscal-year rollup, All industries for other NAICS hubs, and All spending ties for other pairs. None of those links convert this cell into NAICS 541714 biotechnology R&D or a patent-office dashboard, into outlays this packet omits, or into a contractor list. Cite both sides: Research And Development In Nanotechnology and FY2024, $1,052,663,601.95, USAspending.gov, obligations only. NAICS 541713 remains the industry key.

Questions

How much did Research And Development In Nanotechnology show in federal obligations in FY2024?

USAspending.gov records $1,052,663,601.95 in Research And Development In Nanotechnology obligations for FY2024 (NAICS 541713). That is an obligation aggregate for the industry-year pair, not an outlay and not the government-wide FY2024 total. Original filings remain on USAspending.gov.

Is nanotechnology R&D FY2024 an outlay?

No. $1,052,663,601.95 is a yearlyTrend obligation sum, not an outlay. Payments from the Treasury can lag or differ. This packet has no outlay total for Research And Development In Nanotechnology in FY2024. Original filings remain on USAspending.gov.

Does 680 awards mean 680 nanotech labs?

No. 680 is the industry table’s award-record count in this extract, not a published FY2024-only recipient census. Unique vendors and places are unpublished. Modifications can add rows. Original filings remain on USAspending.gov. Keep both the NAICS code and the fiscal year in the citation.

Which pages parent Research And Development In Nanotechnology FY2024?

NAICS 541713 is the industry parent. FY2024 federal spending is the FY2024 parent. All industries lists NAICS hubs. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes Research And Development In Nanotechnology × FY2024 at $1,052,663,601.95.